Search

Displaying results 7551 - 7560 of 10000 in total
  1. Drug

    Enpatoran

    go.drugbank.com/drugs/DB16501
    Investigational

    It was investigated for systemic lupus erythematosus and cutaneous lupus erythematosus in completed trials (NCT04647708 and NCT05162586) and in a recruiting trial (NCT05540327). … Enpatoran (M5049) was under investigation in clinical trials for various conditions.

  2. Drug

    Tyrosinase

    go.drugbank.com/drugs/DB16626
    Investigational

    [A231829, A231834, A231839] Within mammals, tyrosinase is found specifically in melanocytes in a glycosylated form and plays a critical role in regulating the process of melanin biosynthesis (also known … [A231829, A231839] It is recognized as being the main enzyme responsible for enzymatic browning and melanogenesis in mammals, thus causing undesired browning of fruits and vegetables and diseases resulting

  3. Drug

    MK-4965

    go.drugbank.com/drugs/DB08460
    Experimental

    MK-4965 is an HIV-1 reverse transcriptase inhibitor.

  4. Drug

    PD-168393

    go.drugbank.com/drugs/DB07662
    Experimental

    PD-168393 is an epidermal growth factor receptor inhibitor.

  5. Drug

    Narasin

    go.drugbank.com/drugs/DB11432
    ExperimentalVet approved

    Narasin is an agent with coccidiostatic and antibacterial properties.

  6. Drug

    Farabursen

    go.drugbank.com/drugs/DB18127
    Investigational

    RGLS-8429 is an investigational anti-miR-17 oligonucleotide.

  7. Drug

    ST266

    go.drugbank.com/drugs/DB18614
    Investigational

    ST266 is an amniotic membrane-derived cellular cytokine solution.

  8. Drug

    MK-886

    go.drugbank.com/drugs/DB16739
    Experimental

    MK-886 is an experimental inhibitor of leukotriene synthesis.

  9. Drug

    AN-2718

    go.drugbank.com/drugs/DB12810
    Investigational

    An2718 has been used in trials studying Tinea Pedis.

  10. Drug

    Irdabisant

    go.drugbank.com/drugs/DB12900
    Investigational

    Irdabisant has been used in trials studying Cognitive Impairment.